| Serial Number | 85907857 |
| Word Mark | UNIQURE |
| Filing Date | Thursday, April 18, 2013 |
| Status | 705 - PARTIAL SECTION 8 & 15 ACCEPTED AND ACKNOWLEDGED |
| Status Date | Thursday, April 1, 2021 |
| Registration Number | 4710280 |
| Registration Date | Tuesday, March 31, 2015 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 2, 2014 |
| Goods and Services | Viral medicines, gene therapy medicines, nucleic acid delivery medicines, viral vectors, [non-viral vectors,] gene therapy vectors, nucleic acid delivery vectors, [and cells transformed by viral vectors, non-viral vectors, gene therapy vectors and nucleic acid delivery vectors] for medical purposes all for medical treatment of metabolic disorders, [ocular disorders,] diseases of the nervous system, blood disorders, liver disorders, [muscular disorders, muscular skeletal disorders, cancers, infectious diseases, fungal diseases, diseases caused by parasites, diseases affecting the immune system, inflammatory and auto-immune diseases, vascular disorders, bone diseases,] inherited disorders, genetic disorders, single gene disorders [and cancers;] pharmaceutical preparations and substances for the treatment of metabolic disorders, [ocular disorders,] diseases of the nervous system, blood disorders, liver disorders, [muscular disorders, muscular skeletal disorders, cancers, infectious diseases, fungal diseases, diseases caused by parasites, diseases affecting the immune system, inflammatory and auto-immune diseases, vascular disorders, bone diseases,] inherited disorders, genetic disorders, single gene disorders [and cancers;] biological preparations for use in medical and clinical gene therapy, nucleic acid-based therapy [and cell therapy,] all for the treatment of metabolic disorders, [ocular disorders,] diseases of the nervous system, blood disorders, liver disorders, [muscular disorders, muscular skeletal disorders, cancers, infectious diseases, fungal diseases, diseases caused by parasites, diseases affecting the immune system, inflammatory and auto-immune diseases, vascular disorders, bone diseases,]inherited disorders, genetic disorders, single gene disorders [and cancers;] [clinical medical reagents for use in nucleic acid-based therapy, gene therapy, cell therapy, gene diagnosis and gene testing in the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, fungal diseases, diseases caused by parasites, diseases affecting the immune system, inflammatory and auto-immune diseases, vascular disorders, bone diseases, inherited disorders, genetic disorders, single gene disorders and cancers; pharmaceutical preparations, vaccines, prophylaxis medicines and other] pharmaceutical preparations [all] for use in nucleic acid-based therapy, gene therapy [and cell therapy] in the treatment of metabolic disorders, [ocular disorders,] diseases of the nervous system, blood disorders, liver disorders, [muscular disorders, muscular skeletal disorders, cancers, infectious diseases, fungal diseases, diseases caused by parasites, diseases affecting the immune system, inflammatory and auto-immune diseases, vascular disorders, bone diseases,] inherited disorders, genetic disorders, single gene disorders [and cancers] |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | [Viral assays, viral reagents, viral preparations, gene therapy assays, gene therapy reagents, gene therapy preparations, nucleic acid delivery assays, nucleic acid delivery reagents, nucleic acid delivery preparations, viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors and nucleic acid delivery vectors, all for non-medical research purposes] |
| Goods and Services | Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, [ocular disorders,] diseases of the nervous system, blood disorders, liver disorders, [muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders,] inherited disorders, genetic disorders and single gene disorders |
| Goods and Services | Research, product development and consultancy in the field of biotechnology, biologics, pharmaceutics, medical science, chemistry and biochemistry |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | B - Sec. 8 - Class(es) in a Multiple Class registration |
| Class Status Date | Thursday, April 1, 2021 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, April 25, 2013 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, April 25, 2013 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, April 25, 2013 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | uniQure IP B.V. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Amsterdam 1105BP NL |
| Party Name | uniQure IP B.V. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Amsterdam 1105BA NL |
| Party Name | uniQure IP B.V. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Amsterdam 1105BA NL |
| Event Date | Event Description |
| Monday, August 5, 2013 | NON-FINAL ACTION E-MAILED |
| Monday, April 22, 2013 | NEW APPLICATION ENTERED |
| Thursday, April 25, 2013 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, August 5, 2013 | ASSIGNED TO EXAMINER |
| Monday, August 5, 2013 | NON-FINAL ACTION WRITTEN |
| Monday, August 5, 2013 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, July 24, 2014 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Thursday, January 16, 2014 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, January 16, 2014 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sunday, January 26, 2014 | ASSIGNED TO LIE |
| Friday, January 31, 2014 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, January 31, 2014 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, February 22, 2014 | FINAL REFUSAL WRITTEN |
| Saturday, February 22, 2014 | FINAL REFUSAL E-MAILED |
| Saturday, February 22, 2014 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Wednesday, October 29, 2014 | NOTICE OF ALLOWANCE CANCELLED |
| Thursday, July 24, 2014 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, July 24, 2014 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, July 28, 2014 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, July 28, 2014 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Wednesday, August 13, 2014 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 2, 2014 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 2, 2014 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 28, 2014 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, October 29, 2014 | TEAS DELETE 1(B) BASIS RECEIVED |
| Tuesday, November 18, 2014 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
| Tuesday, November 18, 2014 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, March 31, 2015 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, March 31, 2020 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Thursday, September 17, 2020 | TEAS SECTION 8 & 15 RECEIVED |
| Tuesday, November 10, 2020 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Thursday, April 1, 2021 | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| Thursday, April 1, 2021 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| Sunday, March 31, 2024 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
| Friday, October 4, 2024 | TEAS SECTION 8 & 9 RECEIVED |